|
|
Volumn 117, Issue 2, 2014, Pages 373-374
|
|
Upfront chemotherapy with CCNU alone for adults' low-grade gliomas: A clinical analysis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LOMUSTINE;
ALKYLATING AGENT;
ADULT;
ASTROCYTOMA;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER RECURRENCE;
CANCER SURGERY;
CLINICAL EFFECTIVENESS;
CLINICAL EVALUATION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MIDDLE AGED;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
NEUROSURGERY;
NEUTROPENIA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OLIGODENDROGLIOMA;
ONSET AGE;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PROGRESSION FREE SURVIVAL;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT DURATION;
YOUNG ADULT;
ADOLESCENT;
BRAIN NEOPLASMS;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
GLIOMA;
MALE;
MORTALITY;
PATHOLOGY;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
DISEASE-FREE SURVIVAL;
FEMALE;
GLIOMA;
HUMANS;
LOMUSTINE;
MALE;
MIDDLE AGED;
NEOPLASM GRADING;
YOUNG ADULT;
|
|
EID: 84901639998
PISSN: 0167594X
EISSN: 15737373
Source Type: Journal
DOI: 10.1007/s11060-014-1383-8 Document Type: Letter |
|
Times cited : (4)
|
|
References (5)
|
